All companies › ADAG

ADAG · Adagene Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research signal for this company.

0
Open-market buys
0
Open-market sells
1
INSIDER SCANNER signals
—
Last filing

INSIDER SCANNER signals for ADAG

Research signals this company has produced, with the reasoning recorded at the time.

B · LOW conviction · SWING · 2026-08-04
4.11Entry reference
4.52Model target
30.0Max hold (days)
15.0%Model allocation
Luo Peter · CEO

CEO Peter Luo bought a small $85K stake (+15% ownership) with the stock above MA20/MA50 in a healthcare sector beating SPY by ~11%. But price is up 216% off its 52w low and now 12.6% above the insider's buy price, so most of the edge is gone; sub-$100K size and no cluster keep this a small watchlist-tier position.

Watch: Unprofitable biotech, negative FCF; price extended far above 52w low; buy size below $100K threshold; single insider only.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.